The cell therapy product ImmunoArt consists of in vitro expanded allogeneic MSCs from bone marrow, manufactured under the highest GMP standards. The final cell suspension is administered systemically as a bolus in a multiple dose regimen.
Due to its immunomodulatory capacity, the ImmunoART cell therapy product is suitable for the treatment of various diseases where the immune system is deregulated.